Back
AbbVie, Inc. Vs. Merck & Co., Inc. Industry Stock Comparison
Sell
50
ABBV
AbbVie, Inc.
Last Price:
$219.13
Seasonality Move:
2.16%
Buy
74
MRK
Merck & Co., Inc.
Last Price:
$106.74
Seasonality Move:
0.39%
Sell
50
AbbVie, Inc. (ABBV)
is a Sell
Is AbbVie, Inc. a Buy, Sell or Hold?
-
The current AbbVie, Inc. [ABBV] share price is $229.31. The Score for ABBV is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ABBV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Merck & Co., Inc. (MRK)
is a Buy
Is Merck & Co., Inc. a Buy, Sell or Hold?
-
The current Merck & Co., Inc. [MRK] share price is $106.45. The Score for MRK is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
MRK is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ABBV Stock Price Chart
What is AbbVie, Inc.'s stock price today?
-
The AbbVie, Inc. share price today is $229.31Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing slight buying pressure.
MRK Stock Price Chart
What is Merck & Co., Inc.'s stock price today?
-
The Merck & Co., Inc. share price today is $106.45Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRK is experiencing buying pressure, which is a positive indicator for future bullish movement.
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 53.89 | Buy |
| Chaikin Money Flow: | 1439571 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (224.15 - 229.33) | Buy |
| Bollinger Bands (100): | (213.73 - 231.91) | Buy |
MRK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.77 | Buy |
| Relative Strength Index (14 RSI): | 67.03 | Buy |
| Chaikin Money Flow: | 8400784 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (99.07 - 105.31) | Buy |
| Bollinger Bands (100): | (81.88 - 98.46) | Buy |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 229.37 | Sell |
| 20-day SMA: | 226.67 | Buy |
| 50-day SMA: | 226.66 | Buy |
| 200-day SMA: | 206.14 | Buy |
| 8-day EMA: | 228.82 | Buy |
| 20-day EMA: | 227.79 | Buy |
| 50-day EMA: | 226.16 | Buy |
| 200-day EMA: | 210.81 | Buy |
MRK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.92 | Buy |
| 20-day SMA: | 102.01 | Buy |
| 50-day SMA: | 96.24 | Buy |
| 200-day SMA: | 85.65 | Buy |
| 8-day EMA: | 105.23 | Buy |
| 20-day EMA: | 102.74 | Buy |
| 50-day EMA: | 97.62 | Buy |
| 200-day EMA: | 91.26 | Buy |
AbbVie, Inc. Earnings Growth & ABBV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.61 per share, and an increase next year of $1.59 per share.
Merck & Co., Inc. Earnings Growth & MRK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.00 per share.
AbbVie, Inc. Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Merck & Co., Inc. Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||